Robeco Institutional Asset Management’s NovoCure NVCR Stock Holding History

Robeco Institutional Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,792	Closed	-$589K	–	1082
2023 Q1	$589K	Buy	9,792 +1,850	+23%	+$148K	﹤0.01%	838
2022 Q4	$583K	Buy	7,942 +6,965	+713%	+$524K	﹤0.01%	823
2022 Q3	$74K	Sell	977 -1,345	-58%	-$105K	﹤0.01%	898
2022 Q2	$161K	Hold	2,322	–	–	﹤0.01%	845
2022 Q1	$192K	Buy	+2,322	New	+$171K	﹤0.01%	847
2021 Q4	–	Sell	-514	Closed	-$60K	–	938
2021 Q3	$60K	Sell	514 -12,231	-96%	-$1.85M	﹤0.01%	898
2021 Q2	$2.83M	Sell	12,745 -7,442	-37%	-$1.45M	0.01%	658
2021 Q1	$2.67M	Buy	20,187 +4,281	+27%	+$677K	0.01%	631
2020 Q4	$2.75M	Buy	+15,906	New	+$2.18M	0.01%	628

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nordwand Advisors Radnor, Pennsylvania $652M AUM 36.81% 1-Year Est. Return

Robeco Institutional Asset Management's NVCR Position: Q2 2023 in Review

Robeco Institutional Asset Management sold out of NovoCure (NVCR) in Q2 2023, closing a stake of 9,792 shares — an estimated $589K sold.

Robeco Institutional Asset Management first reported a position in NVCR in Q4 2020 and held it in 9 quarters. The position peaked at $2.83M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVCR as of Q2 2023.

Robeco Institutional Asset Management reported no remaining NovoCure position as of Q2 2023 after selling out during the quarter.
Robeco Institutional Asset Management sold 9,792 NovoCure shares in Q2 2023, an estimated $589K.
Robeco Institutional Asset Management first reported a position in NovoCure in Q4 2020 and held it in 9 quarters.
Robeco Institutional Asset Management's NovoCure position peaked at $2.83M in Q2 2021.
267 funds tracked by Wall St. Rank held NovoCure as of Q2 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2023, filed 24 Jul 2023.